🇺🇸 FDA
Pipeline program

Remodulin

Remodulin in ACHD

Unknown small_molecule terminated

Quick answer

Remodulin for Congenital Heart Disease is a Unknown program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Congenital Heart Disease
Phase
Unknown
Modality
small_molecule
Status
terminated

Clinical trials